Monogram Orthopaedics (NASDAQ:MGRM) Issues Quarterly Earnings Results

Monogram Orthopaedics (NASDAQ:MGRM) announced its quarterly earnings results on Wednesday. The company reported ($0.08) earnings per share for the quarter, beating the consensus estimate of ($0.11) by $0.03, Zacks reports.

Monogram Orthopaedics Stock Up 2.2 %

Shares of NASDAQ MGRM traded up $0.05 during trading on Wednesday, hitting $2.32. The company had a trading volume of 42,960 shares, compared to its average volume of 42,627. Monogram Orthopaedics has a fifty-two week low of $1.53 and a fifty-two week high of $4.90. The stock has a fifty day simple moving average of $2.54 and a two-hundred day simple moving average of $2.50. The firm has a market capitalization of $79.60 million, a price-to-earnings ratio of -4.94 and a beta of 1.66.

Analyst Ratings Changes

MGRM has been the topic of a number of recent analyst reports. Roth Capital upgraded shares of Monogram Orthopaedics to a “strong-buy” rating in a research report on Monday, December 9th. Roth Mkm began coverage on Monogram Orthopaedics in a report on Monday, December 9th. They issued a “buy” rating and a $4.00 price objective on the stock.

Monogram Orthopaedics Company Profile

Monogram Orthopaedics, Inc focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures.